How Should Surgery and Hospitalization Be Managed With APS?
At a Glance
People with familial APS should never stop blood thinners on their own before surgery. A hematologist, surgeon, and anesthesia team must create a drug-specific plan for pausing, bridging, restarting, preventing clots, and watching for bleeding.
In this answer
5 sections
Planning for surgery or a hospital stay when you have antiphospholipid syndrome (APS) requires careful coordination to balance the risk of blood clots with the risk of bleeding. Because surgery, physical stress, and prolonged immobility are all strong triggers for abnormal clotting, you must not stop your blood thinners on your own [1]. Instead, a safe surgical experience requires early communication between your specialists, precise drug-specific timing for pausing and restarting medications, and a combination of physical and medical strategies to protect you while you heal [2][3].
Understanding Your Individual Risk
While a diagnosis of “familial APS” indicates an inherited predisposition to the condition, your surgical plan will be based entirely on your individual medical history [4]. Your surgical and anesthesia teams need documentation of your specific APS profile, including your history of blood clots (whether in veins or arteries) and your current antibody test results [4][5]. Being “triple positive” (having all three main APS antibodies: lupus anticoagulant, anticardiolipin, and anti-beta-2-glycoprotein-I) or having a history of arterial clots generally places you in a higher risk category [6]. Your team will also review your kidney and liver function, platelet count, and any past bleeding issues [5].
Before Surgery: Creating a Coordinated Plan
A successful plan involves your surgeon, your anesthesiologist, and the specialist managing your APS (usually a hematologist or rheumatologist) [3].
You should provide a complete list of everything you take, not just prescription blood thinners. This includes aspirin, antiplatelet drugs (like clopidogrel), nonsteroidal anti-inflammatory drugs (NSAIDs), and herbal supplements, all of which can alter your bleeding risk. Do not stop any of these without specific directions from your care team.
Managing Blood Thinners (Anticoagulation)
An unplanned interruption of anticoagulation increases your risk of clotting and, combined with the stress of surgery, can sometimes precipitate a rare, life-threatening condition called Catastrophic APS (CAPS) [1][7]. A carefully planned, clinician-directed pause is essential.
Warfarin and “Bridging” Therapy
For most people with thrombotic APS, warfarin remains the preferred long-term blood thinner [4]. If warfarin must be paused for surgery, your team will decide if you need bridging therapy—temporarily using a shorter-acting injectable blood thinner, like low-molecular-weight heparin (LMWH) [2].
Bridging is not automatic. While it reduces clot risk, it also significantly increases the risk of major surgical bleeding [2]. Doctors consider therapeutic-dose (full-dose) bridging for high-risk patients based on factors like triple-positive status, recent clots, prior arterial clots, and the bleeding risk of the specific procedure [8].
Direct Oral Anticoagulants (DOACs)
Direct Oral Anticoagulants (such as apixaban, rivaroxaban, dabigatran, and edoxaban) are generally discouraged for high-risk APS due to higher rates of arterial clots compared to warfarin [9][10]. If you have lower-risk venous APS and are taking a DOAC under specialist guidance, the timing for pausing the drug depends heavily on the specific medication, your exact kidney function (creatinine clearance), and the surgery’s bleeding risk [11]. Because different DOACs are cleared by the kidneys at very different rates, you must follow an agent-specific plan [11].
Anesthesia Considerations
If your surgery involves neuraxial anesthesia (a spinal block or epidural), there are strict safety intervals for when blood thinners must be stopped and when they can be restarted [12]. These rules apply to both the placement of the needle or catheter and its removal [13]. Timing depends on the specific drug, the dose, and your kidney function—not just a standard number of hours [12].
Hospitalization: Protecting Yourself While You Heal
Even with careful medication management, the physical stress of surgery and limited mobility raise your risk of developing a deep vein thrombosis (DVT) or pulmonary embolism (PE) [14][15]. Your hospital care may include:
- Movement: Getting out of bed and walking as soon as it is medically safe is critical to keeping blood circulating.
- Mechanical Compression: Devices like elastic compression stockings or intermittent pneumatic compression boots may be used to gently squeeze your legs, provided you do not have severe arterial disease or skin injury [16]. These do not replace medication.
- Hydration: You should consume fluids as permitted by your care team to avoid dehydration, though hydration alone does not prevent APS clots, and excessive fluids can be unsafe if you have heart or kidney issues [17].
- Pharmacologic Prophylaxis: After surgery, you may receive a lower, “prophylactic” (preventative) dose of an injectable blood thinner before it is safe to resume your full therapeutic dose [18].
Restarting Your Medications
There is no single transition schedule for restarting medications. Often, warfarin is restarted at your usual prescribed dose once surgical bleeding is controlled (hemostasis), while injectable heparin may be continued until your blood tests show the warfarin is fully active again [4]. DOACs are typically restarted at their prescribed dose once hemostasis is secure. Follow your written, drug-specific plan and never adjust doses on your own.
Emergency Warning Signs
Monitor yourself closely after discharge. Seek immediate medical attention if you experience:
- Signs of a DVT or PE: Sudden shortness of breath, chest pain, coughing up blood, or unexplained swelling, redness, or pain in one leg.
- Signs of Arterial Clots: Sudden weakness or numbness in the face, arm, or leg (especially on one side), difficulty speaking, or vision changes.
- Signs of Major Bleeding: Uncontrolled wound bleeding, vomiting blood, or black/tarry stools.
- Signs of Spinal Bleeding (if you had an epidural/spinal): New back pain, leg weakness, numbness, or loss of bladder or bowel control.
Common questions in this guide
Should I stop my blood thinner before surgery if I have familial APS?
How do doctors decide whether I need heparin bridging for APS surgery?
Are DOACs safe to use around surgery with APS?
How can I lower my clot risk while hospitalized after APS surgery?
What symptoms require emergency help after APS surgery?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Who is the single clinician or service responsible for documenting my medication plan and managing my blood thinners while I am hospitalized and at discharge?
- 2.Based on my specific APS profile, clot history, and the procedure's bleeding risk, do you recommend therapeutic bridging, prophylactic bridging, or no bridging while my main blood thinner is paused?
- 3.What is the exact day and time I should take my last dose of blood thinner (and any antiplatelet medication) before the procedure, and what exact milestone determines when it is safe to restart them?
- 4.Will I be receiving epidural or spinal anesthesia, and how does the placement and removal of the catheter dictate the timing of my blood thinners?
- 5.What mechanical clot prevention methods are safe and appropriate for me to use while I am in bed recovering?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.
Stammler R, Nguyen Y, Yelnik C, et al.
Journal of thrombosis and haemostasis : JTH 2023; (21(5)):1258-1265 doi:10.1016/j.jtha.2023.02.007.
PMID: 36792010 - 2
Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings.
Nikolakopoulos I, Spyropoulos AC
Seminars in thrombosis and hemostasis 2020; (46(1)):26-31 doi:10.1055/s-0039-1696945.
PMID: 31830765 - 3
A Rare Case of Tricuspid Valve Libman-Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome.
Migliorini S, Santoro C, Scatteia A, et al.
Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195875.
PMID: 36233742 - 4
EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG, Andreoli L, Limper M, et al.
Annals of the rheumatic diseases 2019; (78(10)):1296-1304 doi:10.1136/annrheumdis-2019-215213.
PMID: 31092409 - 5
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
Sayar Z, Moll R, Isenberg D, Cohen H
Thrombosis research 2021; (198()):213-221 doi:10.1016/j.thromres.2020.10.010.
PMID: 33485122 - 6
Diagnosis and management of the antiphospholipid syndrome.
Chaturvedi S, McCrae KR
Blood reviews 2017; (31(6)):406-417 doi:10.1016/j.blre.2017.07.006.
PMID: 28784423 - 7
Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C, Jego P, Veyssier-Belot C, et al.
Lupus 2017; (26(12)):1291-1296 doi:10.1177/0961203317699285.
PMID: 28355985 - 8
Perioperative management of antithrombotic therapy in patients with thrombotic antiphospholipid syndrome.
Paquette M, Miranda S, Xu Y, et al.
Blood advances 2026; (10(9)):3218-3228 doi:10.1182/bloodadvances.2026019610.
PMID: 41843780 - 9
Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines.
Pastori D, Menichelli D, Cammisotto V, Pignatelli P
Frontiers in cardiovascular medicine 2021; (8()):715878 doi:10.3389/fcvm.2021.715878.
PMID: 34414220 - 10
Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials.
Lee YH, Song GG
Lupus 2022; (31(11)):1335-1343 doi:10.1177/09612033221118463.
PMID: 35968627 - 11
Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure.
Padrini R
European journal of drug metabolism and pharmacokinetics 2019; (44(1)):1-12 doi:10.1007/s13318-018-0501-y.
PMID: 30167998 - 12
The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants.
Leffert L, Butwick A, Carvalho B, et al.
Anesthesia and analgesia 2018; (126(3)):928-944 doi:10.1213/ANE.0000000000002530.
PMID: 29099429 - 13
Influence of antithrombotic medication on size and neurological outcome of spinal epidural hematoma after neuraxial anesthesia: a systematic review.
Schieber MR, Schubert AK, Hubner W, Volk T
Regional anesthesia and pain medicine 2025; (50(1)):20-25 doi:10.1136/rapm-2023-104864.
PMID: 38129095 - 14
Antiphospholipid Syndrome Increases Postoperative Complications After Total Hip and Knee Arthroplasty.
Hirpara A, Carpenter M, Dayton M, Hogan C
Orthopedics 2024; (47(5)):301-307 doi:10.3928/01477447-20240619-03.
PMID: 38935847 - 15
Antiphospholipid Syndrome in Orthopaedic Foot and Ankle Surgery: A Propensity-Matched Analysis.
Mody K, Chopra AA, Greenberg M, et al.
Foot & ankle orthopaedics 2025; (10(4)):24730114251393650 doi:10.1177/24730114251393650.
PMID: 41647461 - 16
Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholipid Syndrome and Decreased Cardiac Function: A Case Study.
Shibuya M, Kimura Y, Takuma S, et al.
Anesthesia progress 2021; (68(1)):33-37 doi:10.2344/anpr-67-03-07.
PMID: 33827125 - 17
Antiphosphatidylserine Antibody as a Cause of Multiple Dural Venous Sinus Thromboses and ST-Elevation Myocardial Infarction.
Varner CK, Marquardt CW, Pickens PV
The American journal of case reports 2018; (19()):1042-1046 doi:10.12659/AJCR.909698.
PMID: 30166503 - 18
The antiphospholipid syndrome in patients with systemic lupus erythematosus.
Pons-Estel GJ, Andreoli L, Scanzi F, et al.
Journal of autoimmunity 2017; (76()):10-20 doi:10.1016/j.jaut.2016.10.004.
PMID: 27776934
This page explains surgery and hospitalization planning for familial APS for informational purposes only and does not constitute medical advice. Your hematologist, rheumatologist, surgeon, and anesthesiologist should create your individualized medication and anesthesia plan.
Get notified when new evidence is published on familial antiphospholipid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.